MoneyWorks4Me

Biocon - Quaterly Results

08 Feb 2024 Evaluate
A minor change in the total revenue was seen in the December 2023 quarter. The total revenue for the quarter stood at Rs. 5628.00 millions against Rs. 5550.00 millions during year ago period.A big decline of -31.82% was reported for the quarter ended December 2023 to Rs. 240.00  millions from Rs. 352.00 millions of corresponding previous quarter.Operating profit surged to 1198.00 millions from the corresponding previous quarter of 970.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 5628.00 5550.00 1.41 15947.00 14862.00 7.30 19929.00 17382.00 14.65
Other Income 485.00 599.00 -19.03 1541.00 2074.00 -25.70 2714.00 1872.00 44.98
PBIDT 1198.00 970.00 23.51 3646.00 2749.00 32.63 2949.00 2483.00 18.77
Interest 560.00 214.00 161.68 1593.00 215.00 640.93 696.00 4.00 17300.00
PBDT 638.00 756.00 -15.61 2198.00 12626.00 -82.59 30881.00 2479.00 1145.70
Depreciation 309.00 291.00 6.19 913.00 875.00 4.34 1169.00 1082.00 8.04
PBT 329.00 465.00 -29.25 1285.00 11751.00 -89.06 29712.00 1397.00 2026.84
TAX 89.00 113.00 -21.24 232.00 1375.00 -83.13 1228.00 536.00 129.10
Deferred Tax -34.00 -11.00 209.09 -12.00 -89.00 -86.52 0.00 0.00 0.00
PAT 240.00 352.00 -31.82 1053.00 10376.00 -89.85 28484.00 861.00 3208.25
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 21.29 17.48 21.79 22.86 18.50 23.61 14.80 14.28 3.59
Peers
Company Name CMP
Sun Pharma. Inds. 1791.95
Dr. Reddys Labs. 1200.55
Cipla 1323.45
Lupin 2001.10
Zydus Lifesciences 1135.00
View more..